MARC record from Internet Archive

LEADER: 05407cam 2200949 a 4500
001 ocm35836718
003 OCoLC
005 20200521034111.0
008 961015s1996 nyua b 101 0 eng
010 $a 96037079
040 $aDNLM/DLC$beng$cDLC$dNLM$dGZM$dAGL$dSQU$dBTCTA$dZWZ$dBDX$dOCLCO$dOCLCF$dUKM$dBAKER$dNLGGC$dYDXCP$dCRU$dGEBAY$dOCLCO$dOCLCQ$dOCLCO$dOCL$dOCLCO$dOCLCQ$dOCLCO$dTJC$dUKMGB$dOCLCO$dOCLCA
015 $aGB9704558$2bnb
016 7 $a9615940$2DNLM
016 7 $a006371449$2Uk
019 $a36260911
020 $z0306455048
020 $a9780306455049
020 $a0306455048
020 $z0308455048
035 $a(OCoLC)35836718$z(OCoLC)36260911
050 00 $aRB155.8$b.T37 1996
060 00 $a1997 E-982
060 10 $aQU 57$bT185 1996
070 0 $aQH301.N32$bv.290
072 0 $aX300
072 0 $aX380
082 00 $a616/.042$221
084 $a44.47$2bcl
245 00 $aTargeting of drugs 5 :$bstrategies for oligonucleotide and gene delivery in therapy /$cedited by Gregory Gregoriadis and Brenda McCormack.
246 30 $aTargeting of drugs five
260 $aNew York :$bPlenum,$c©1996.
300 $aviii, 206 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aNATO ASI series. Series A, Life sciences ;$vv. 290
500 $a"Published in cooperation with NATO Scientific Affairs Division."
500 $a"Proceedings of a NATO Advanced Study Institute on Targeting of Drugs: Strategies for Oligonucleotide and Gene Delivery in Therapy, held June 24-July 5, 1995, in Cape Sounion, Greece"--Title page verso.
504 $aIncludes bibliographical references and index.
505 0 $aGene therapy for inherited genetic disease: possibilities and problems -- Gene delivery and therapy: the case for cystic fibrosis -- Immune responses with direct gene transfer: DNA vaccines and implications for gene therapy -- Oligonucleotides: molecular versions for optimal use in vivo -- Retrovirus vectors in gene therapy: targeting to specific cells -- Adenovirus as vectors for gene therapy -- Receptor-mediated gene delivery with synthetic virus-like particles -- Controllable gene therapy: recent advances in non-viral gene delivery -- Genetic chemistry: towards non-enzymatic ligation, sequence-selective recognition of DNA, and self-assembling systems for gene delivery -- Integrin-medicated gene delivery -- Design, synsthesis, and cellular delivery of antibody targeted, radiolabelled oligonucleotide conjugates for cancer therapy -- Poly(L lysine) mediated delivery of nucleic acids -- Complement activation by polylysine-DNA complexes -- Nanoparticles as carriers for antisense oligonucleotides -- Efficient incorporation of plasmid DNA within liposomes of varying structural characteristics; liposomal DNA integrity and transfection efficiency -- pH sensitive liposomes as efficient carries for intracellular delivery of oligonucleotides -- Liposomal delivery of p-ethoxy antisense oligodeoxynucleotides in chronic myelogenous leukemia -- Liposome-mediated delivery of genes and oligonucleotides for the treatment of brain tumors -- Enzyme assisted synthesis of delivery systems.
650 0 $aGene therapy$vCongresses.
650 0 $aDrug targeting$vCongresses.
650 0 $aOligonucleotides$xTherapeutic use$vCongresses.
650 7 $aVecteurs de médicaments$xActes de congrès.$2fmesh
650 7 $aPréparations pharmaceutiques.$2fmesh
650 7 $aThérapie génique.$2fmesh
650 7 $aOligonucléotides$xusage thérapeutique.$2fmesh
650 7 $aCiblage de gène.$2fmesh
650 7 $aDrug targeting.$2fast$0(OCoLC)fst00898709
650 7 $aGene therapy.$2fast$0(OCoLC)fst00939638
650 7 $aOligonucleotides$xTherapeutic use.$2fast$0(OCoLC)fst01045458
650 7 $aMédicaments$xRécepteurs$xCongrès.$2ram
650 7 $aThérapie génique.$2ram
650 7 $aVecteurs de médicaments.$2ram
650 7 $aArzneimittel$2gnd
650 7 $aTransport$2gnd
650 7 $aArzneistoffträger$2gnd
650 12 $aOligonucleotides, Antisense$xtherapeutic use.
650 22 $aDrug Delivery Systems.
650 22 $aGene Targeting$xmethods.
650 22 $aGenetic Therapy.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.
700 1 $aGregoriadis, Gregory.
700 1 $aMcCormack, Brenda.
710 2 $aNorth Atlantic Treaty Organization.$bScientific Affairs Division.
711 2 $aNATO Advanced Study Institute on Targeting of Drugs: Strategies for Oligonucleotide and Gene Delivery in Therapy$d(1995 :$cAkra Sounion, Greece)
776 08 $iOnline version:$tTargeting of drugs 5.$dNew York : Plenum, ©1996$w(OCoLC)743290073
830 0 $aNATO ASI series.$nSeries A,$pLife sciences ;$vv. 290.
938 $aBaker & Taylor$bBKTY$c166.00$d166.00$i0306455048$n0002936142$sactive
938 $aBrodart$bBROD$n50446312$c$85.00
938 $aBaker and Taylor$bBTCP$n96037079 //r98
938 $aYBP Library Services$bYANK$n1337764
029 1 $aAU@$b000012861687
029 1 $aAU@$b000012989583
029 1 $aAU@$b000052928902
029 1 $aGEBAY$b2641332
029 1 $aNLGGC$b163709572
029 1 $aNLM$b9615940
029 1 $aUKMGB$b006371449
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 74 OTHER HOLDINGS